Pharmaceutical industry
Biopharma companies are facing increased scrutiny over high prices, but EQRx is taking a bold approach by pricing its drugs 50% to 70% below competition. Meanwhile, the FDA has fully approved Pfizer's COVID-19 vaccine, and biopharma companies are offering six-figure salaries to attract top talent. Key Takeaways: * EQRx&
Pharmaceutical industry
The global market for anti-inflammatory therapeutics is projected to reach $130.9 billion by 2026, growing at a compound annual growth rate (CAGR) of 4.8% over the analysis period. The market is expected to experience significant growth due to the increasing prevalence of chronic inflammatory diseases, such as arthritis,
Pharmaceutical industry
Amidst the ongoing COVID-19 crisis, the global market for Active Pharmaceutical Ingredients/API is projected to witness significant growth, expanding from an estimated $204.2 billion in 2020 to reach $274.8 billion by 2026, at a compound annual growth rate (CAGR) of 4.9%. This market growth is driven
Pharmaceutical industry
The Judicial Panel on Multidistrict Litigation has transferred the Zantac (Ranitidine) Products Liability Litigation to the Southern District of Florida, with the support of the defendants, who include Sanofi-Aventis U.S. LLC, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline LLC, and others. The Panel held that the action involves common questions of
Pharmaceutical industry
DelveInsight's report on the Multiple Myeloma pipeline landscape provides a comprehensive overview of the therapies and companies working towards a cure for this debilitating disease. With over 80 companies and 120 pipeline drugs in development, the future of Multiple Myeloma treatment looks promising. The report covers the pipeline
Pharmaceutical industry
The global kidney cancer diagnostic and therapeutic market is projected to grow at a considerable compound annual growth rate (CAGR) of 6.8% during the forecast period 2020-2026, driven by the increasing prevalence of kidney cancer, changing lifestyles, and the endorsement of novel drugs for treatment. The market is segmented
Pharmaceutical industry
The global intranasal drug delivery market is projected to reach $71.3 billion by 2026, growing at a CAGR of 6.2% over the analysis period. The market is driven by the growing awareness among physicians and patients about the benefits of intranasal drug delivery, technological advancements, and the increasing
Pharmaceutical industry
British American Tobacco, Wizz Air, and GlaxoSmithKline will release their half-year results, while the Federal Reserve makes its latest decision on interest rates. UBS forecasts a strong adjustment for Barclays, with a potential [pounds]1.8bn adjusted profit before tax. The tobacco industry is under pressure, but BAT has managed
Pharmaceutical industry
German biotech company BioNTech SE has announced a project to develop a malaria vaccine candidate using its proprietary mRNA technology, backed by the eradicateMalaria initiative. This ambitious goal aims to expand vaccine production capacity across Africa and follows a two-pronged approach: developing a first-generation vaccine using a known antigen and
Pharmaceutical industry
A registered nurse at Iowa's maximum-security Iowa State Penitentiary has appealed her termination after being fired for accidentally giving dozens of inmates large overdoses of the coronavirus vaccine. Amanda Dodson, a 17-year corrections department employee, was terminated along with another nurse, Stephen Sherman, after an investigation found 77
Pharmaceutical industry
A controversy emerged in Scotland when the government's vaccine deployment plan, published on January 13, included commercially sensitive information about vaccine supplies, breaching confidentiality agreements with manufacturers Pfizer and AstraZeneca. The plan was subsequently removed from the Scottish Government website, and the document was reuploaded on January 14
Pharmaceutical industry
Moderna Inc. jumped to a fresh record after S&P Dow Jones Indices said it plans to add the company to its benchmark S&P 500 Index next week, replacing Alexion Pharmaceuticals Inc. Meanwhile, its market valuation has surpassed $100 billion, making it one of the largest biotech
